Clinical Trials Directory

Trials / Unknown

UnknownNCT06108453

A Drug-drug Interaction Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Methotrexate in Elderly Subjects

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Seoul National University Bundang Hospital · Academic / Other
Sex
All
Age
70 Years – 80 Years
Healthy volunteers
Accepted

Summary

To investigate the effect of rifampicin on the pharmacokinetics of methotrexate.

Conditions

Interventions

TypeNameDescription
DRUGMethotrexate SodiumMethotrexate oral administration alone
DRUGRifampicinCo-administration of methotrexate and rifampicin

Timeline

Start date
2023-08-21
Primary completion
2024-10-24
Completion
2024-11-24
First posted
2023-10-31
Last updated
2023-10-31

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT06108453. Inclusion in this directory is not an endorsement.

A Drug-drug Interaction Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Methotrexate in Elderly Su (NCT06108453) · Clinical Trials Directory